Matthew Winton, Chief Commercial and Business at CervoMed Inc. (CRVO), bought 10,000 shares at $7.57 ($76K) on 2025-11-14, disclosed to the SEC on 2025-11-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.